NFX vs. PYC, OBD, RENE, SALV, OCTP, OVB, VAL, PEBI, ABZA, and VER
Should you be buying Nuformix stock or one of its competitors? The main competitors of Nuformix include Physiomics (PYC), Oxford BioDynamics (OBD), ReNeuron Group (RENE), SalvaRx Group (SALV), Oxford Cannabinoid Technologies (OCTP), Ovoca Bio (OVB), ValiRx (VAL), Port Erin Biopharma Investments (PEBI), Abzena (ABZA), and Vernalis (VER). These companies are all part of the "biotechnology" industry.
Nuformix vs.
Nuformix (LON:NFX) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, community ranking, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.
Physiomics has higher revenue and earnings than Nuformix.
Nuformix has a net margin of 0.00% compared to Physiomics' net margin of -106.80%. Nuformix's return on equity of -27.25% beat Physiomics' return on equity.
Physiomics received 12 more outperform votes than Nuformix when rated by MarketBeat users. However, 66.67% of users gave Nuformix an outperform vote while only 55.56% of users gave Physiomics an outperform vote.
Nuformix has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Physiomics has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500.
0.1% of Nuformix shares are owned by institutional investors. 12.4% of Nuformix shares are owned by insiders. Comparatively, 4.2% of Physiomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Nuformix's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.
Summary
Nuformix beats Physiomics on 8 of the 11 factors compared between the two stocks.
Get Nuformix News Delivered to You Automatically
Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuformix Competitors List
Related Companies and Tools
This page (LON:NFX) was last updated on 1/25/2025 by MarketBeat.com Staff
